Erytech – We are a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases.

The Erytech Team wishes you a Happy and Healthy year 2022 !

We are a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases

To learn more about Erytech's phase 3 clinical trial in pancreatic cancer

View the webcast of our KOL event on our lead product, eryaspase, in pancreatic cancer with Dr. Hidalgo and Dr. Noel

Home